Show simple item record

dc.contributor.authorLu, L.
dc.contributor.authorGuo, J.
dc.contributor.authorHua, Y.
dc.contributor.authorHuang, K.
dc.contributor.authorMagaye, R.
dc.contributor.authorCornell, J.
dc.contributor.authorKelly, D.
dc.contributor.authorReid, Christopher
dc.contributor.authorLiew, D.
dc.contributor.authorZhou, Y.
dc.contributor.authorChen, A.
dc.contributor.authorXiao, W.
dc.contributor.authorFu, Q.
dc.contributor.authorWang, B.
dc.date.accessioned2017-10-30T08:16:14Z
dc.date.available2017-10-30T08:16:14Z
dc.date.created2017-10-30T08:03:08Z
dc.date.issued2017
dc.date.submitted2017-10-30
dc.identifier.citationLu, L. and Guo, J. and Hua, Y. and Huang, K. and Magaye, R. and Cornell, J. and Kelly, D. et al. 2017. Cardiac fibrosis in the ageing heart: Contributors and mechanisms. Clinical and Experimental Pharmacology and Physiology.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/57233
dc.identifier.doi10.1111/1440-1681.12753
dc.description.abstract

© 2017 John Wiley & Sons Australia, Ltd. Cardiac fibrosis refers to an excessive deposition of extracellular matrix (ECM) in cardiac tissue. Fibrotic tissue is stiffer and less compliant, resulting in subsequent cardiac dysfunction and heart failure. Cardiac fibrosis in the ageing heart may involve activation of fibrogenic signalling and inhibition of anti-fibrotic signalling, leading to an imbalance of ECM turnover. Excessive accumulation of ECM such as collagen in older patients contributes to progressive ventricular dysfunction. Overexpression of collagen is derived from various sources, including higher levels of fibrogenic growth factors, proliferation of fibroblasts and cellular transdifferentiation. These may be triggered by factors, such as oxidative stress, inflammation, hypertension, cellular senescence and cell death, contributing to age-related fibrotic cardiac remodelling. In this review, we will discuss the fibrogenic contributors in age-related cardiac fibrosis, and the potential mechanisms by which fibrogenic processes can be interrupted for therapeutic intent.

dc.publisherWiley-Blackwell Publishing Asia
dc.titleCardiac fibrosis in the ageing heart: Contributors and mechanisms
dc.typeJournal Article
dcterms.dateSubmitted2017-10-30
dcterms.source.issn0305-1870
dcterms.source.titleClinical and Experimental Pharmacology and Physiology
curtin.digitool.pid256131
curtin.pubStatusIn Press
curtin.refereedTRUE
curtin.departmentDepartment of Health Policy and Management
curtin.identifier.scriptidPUB-VC-ORD-SA-20708
curtin.identifier.elementsidELEMENTS-193667
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record